Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Autologous Superficial Femoral Vein for Aortic Reconstruction in Infected Fields

Autologous Superficial Femoral Vein for Aortic Reconstruction in Infected Fields Autologous Superficial Femoral Vein for Aortic Reconstruction in Infected Fields Philip M. Brown, Jr., MD, Victor B. Kim, MD, Janice F. Lalikos, MD, David H. Deaton, MD, William M. Bogey, MD, and C. Steven Powell, MD, Greenville, North Carolina Autogenous reconstruction is one option available for patients with aortic graft infection or mycotic aneurysms. We reviewed our recent institutional experience with all patients undergoing aortic reconstruction using autologous superficial femoral vein (SFV). Between February 1995 and November 1997, eight patients (five with prosthetic aortic graft infection and three with mycotic aneurysms, including one ruptured mycotic aneurysm) underwent single-stage aortic reconstruction using autologous SFV. Therapy for graft infection included graft excision and replacement with aortobifemoral or aortofemoral (with subsequent cross femoral) grafts fash- ioned from the SFV. The two patients undergoing elective repair of mycotic aneurysms were treated with extensive SFV patches, and the patient with a ruptured mycotic aneurysm under- went SFV tube grafting. Autogenous reconstruction of the aorta using the SFV in infected fields shows promise for salvage of life and limb during early experiences and short-term follow-up. Morbidity and mortality rates compare favorably with those from existing series, reconstruction is anatomic, and reinfection potential is low. Long-term http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Vascular Surgery Springer Journals

Autologous Superficial Femoral Vein for Aortic Reconstruction in Infected Fields

Loading next page...
 
/lp/springer-journals/autologous-superficial-femoral-vein-for-aortic-reconstruction-in-yq0vuFz77f

References (12)

Publisher
Springer Journals
Copyright
Copyright © 1999 by Annals of Vascular Surgery Inc.
Subject
Medicine & Public Health; Abdominal Surgery
ISSN
0890-5096
eISSN
1615-5947
DOI
10.1007/s100169900217
pmid
9878654
Publisher site
See Article on Publisher Site

Abstract

Autologous Superficial Femoral Vein for Aortic Reconstruction in Infected Fields Philip M. Brown, Jr., MD, Victor B. Kim, MD, Janice F. Lalikos, MD, David H. Deaton, MD, William M. Bogey, MD, and C. Steven Powell, MD, Greenville, North Carolina Autogenous reconstruction is one option available for patients with aortic graft infection or mycotic aneurysms. We reviewed our recent institutional experience with all patients undergoing aortic reconstruction using autologous superficial femoral vein (SFV). Between February 1995 and November 1997, eight patients (five with prosthetic aortic graft infection and three with mycotic aneurysms, including one ruptured mycotic aneurysm) underwent single-stage aortic reconstruction using autologous SFV. Therapy for graft infection included graft excision and replacement with aortobifemoral or aortofemoral (with subsequent cross femoral) grafts fash- ioned from the SFV. The two patients undergoing elective repair of mycotic aneurysms were treated with extensive SFV patches, and the patient with a ruptured mycotic aneurysm under- went SFV tube grafting. Autogenous reconstruction of the aorta using the SFV in infected fields shows promise for salvage of life and limb during early experiences and short-term follow-up. Morbidity and mortality rates compare favorably with those from existing series, reconstruction is anatomic, and reinfection potential is low. Long-term

Journal

Annals of Vascular SurgerySpringer Journals

Published: Apr 28, 2014

There are no references for this article.